Koyfin Home > Directory > Health Care > Acorda Therapeutics > Price / Earnings (ltm)

Acorda Therapeutics Price / Earnings (ltm) Chart (ACOR)

Acorda Therapeutics annual/quarterly Price / Earnings (ltm) from 2011 to 2019. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Acorda Therapeutics Price / Earnings (ltm) for the quarter ending May 05, 2019 was 14.15 a -9.65% decrease of -1.37 year over year
  • Acorda Therapeutics Price / Earnings (ltm) for the last 12 months ending May 05, 2019 was 14.15 a -9.65% decrease of -1.37 year over year
  • Acorda Therapeutics Annual Price / Earnings (ltm) for 2019 was 14.15 a -3.98% decrease of -0.56 from 2018
  • Acorda Therapeutics Annual Price / Earnings (ltm) for 2019 was 14.72 a -6.79% decrease of -1.00 from 2018
  • Acorda Therapeutics Annual Price / Earnings (ltm) for 2019 was 15.72 a 1.25% increase of 0.20 from 2018
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR Price / Earnings (ltm) Data

05/201914.15
04/201914.72
04/201915.72
04/201915.52
04/201915.75
04/201915.73
04/201915.96
04/201915.38
04/201915.69
04/201916.32

Annual ACOR Price / Earnings (ltm) Data

201914.15
201914.72
201915.72
201915.52
201915.75
201915.73
201915.96
201915.38
201915.69
201916.32